Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07807969 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Name: An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) — clinical trial record (NCT07807969)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: AiiM OLE

StatusNot Yet Recruiting

PhasePhase 3

SponsorAnnexon, Inc.

Started2026-09-30

View on ClinicalTrials.gov ↗

Annexon, Inc.

5 trials monitored

See 1 trial at risk

The primary purpose of the study is to assess the long term safety of intravitreal (IVT) injections of vonaprument.

Trial Details

NCT Number	NCT07807969
Lead Sponsor	Annexon, Inc.
Conditions	Geographic Atrophy
Enrollment	605 participants
Start Date	2026-09-30
Primary Completion	2029-07-31 (estimated)
Study Completion	2029-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-09-08